SB 614

  • Virginia Senate Bill
  • 2024 Regular Session
  • Introduced in Senate Jan 10, 2024
  • Passed Senate Feb 09, 2024
  • Passed House Feb 26, 2024
  • Signed by Governor Apr 04, 2024

Xylazine; penalty for manufacturing, selling, etc., for human consumption.

Abstract

Xylazine; manufacturing; selling; giving; distributing; possessing; veterinary use exemption; penalties. Provides that any person who knowingly manufactures, sells, gives, distributes, or possesses with the intent to manufacture, sell, give, or distribute the substance xylazine, when intended for human consumption, is guilty of a Class 5 felony. Under the bill, any person who knowingly possesses xylazine, when intended for human consumption, is guilty of a Class 1 misdemeanor. Under the bill, it is not an offense to (i) manufacture xylazine for legitimate veterinary use; (ii) distribute or sell xylazine for authorized veterinary use; (iii) possess, administer, prescribe, or dispense xylazine in good faith for use by animals within the course of legitimate veterinary practice; or (iv) possess or administer xylazine pursuant to a valid prescription from a licensed veterinarian. This bill is identical to HB 1187.

Schedule III drugs. Adds xylazine to thelist of Schedule III drugs.

Bill Sponsors (2)

Votes


Actions


Apr 04, 2024

Office of the Governor

Acts of Assembly Chapter text (CHAP0516)

Office of the Governor

Approved by Governor-Chapter 516 (effective 7/1/24)

Mar 11, 2024

Senate

Enrolled Bill Communicated to Governor on March 11, 2024

Office of the Governor

Governor's Action Deadline 11:59 p.m., April 8, 2024

Mar 03, 2024

Senate

Signed by President

Feb 29, 2024

Senate

Bill text as passed Senate and House (SB614ER)

House

Signed by Speaker

Senate

Impact statement from DPB (SB614ER)

Senate

Enrolled

Feb 26, 2024

House

Passed House BLOCK VOTE (96-Y 0-N)

House

VOTE: Block Vote Passage (96-Y 0-N)

House

Read third time

Feb 23, 2024

House

Read second time

Feb 21, 2024

House

Reported from Appropriations (22-Y 0-N)

Feb 16, 2024

House

Referred to Committee on Appropriations

House

Reported from Courts of Justice (22-Y 0-N)

Feb 15, 2024

House

Read first time

House

Placed on Calendar

House

Referred to Committee for Courts of Justice

Feb 09, 2024

Senate

Passed Senate (40-Y 0-N)

Senate

Read second time

Senate

Reading of substitute waived

Senate

Committee substitute agreed to 24106043D-S1

Senate

Engrossed by Senate - committee substitute SB614S1

Senate

Constitutional reading dispensed (40-Y 0-N)

Feb 08, 2024

Senate

Constitutional reading dispensed (40-Y 0-N)

Feb 07, 2024

Senate

Reported from Finance and Appropriations (15-Y 0-N)

Feb 05, 2024

Senate

Impact statement from DPB (SB614S1)

Senate

Rereferred to Finance and Appropriations

Senate

Reported from Courts of Justice (15-Y 0-N)

Feb 02, 2024

Senate

Impact statement from VCSC (SB614S1)

Feb 01, 2024

Senate

Committee substitute printed 24106043D-S1

Senate

Rereferred to Courts of Justice

Senate

Reported from Education and Health with substitute (15-Y 0-N)

Jan 26, 2024

Senate

Senate subcommittee amendments and substitutes offered

Jan 25, 2024

Senate

Impact statement from DPB (SB614)

Jan 16, 2024

Senate

Assigned Education and Health Sub: Health Professions

Jan 12, 2024

Senate

Impact statement from VCSC (SB614)

Jan 10, 2024

Senate

Referred to Committee on Education and Health

Senate

Prefiled and ordered printed; offered 01/10/24 24104627D

Bill Text

Bill Text Versions Format
Prefiled and ordered printed; offered 01/10/24 24104627D PDF HTML
Committee substitute printed 24106043D-S1 PDF HTML
SB614ER PDF HTML
CHAP0516 PDF HTML

Related Documents

Document Format
Fiscal Impact Statement: SB614FER122.PDF PDF
Fiscal Impact Statement: SB614FS1122.PDF PDF
Fiscal Impact Statement: SB614FS1160.PDF PDF
Fiscal Impact Statement: SB614F122.PDF PDF
Fiscal Impact Statement: SB614F160.PDF PDF

Sources

Data on Open States is updated periodically throughout the day from the official website of the Virginia General Assembly.

If you notice any inconsistencies with these official sources, feel free to file an issue.